Drug data last refreshed 16h ago · AI intelligence enriched 3w ago
TALWIN (pentazocine lactate) is an opioid analgesic administered by injection for moderate to severe pain relief. As a mixed opioid agonist-antagonist, it provides analgesia with a lower abuse potential profile compared to pure mu-agonist opioids. This injectable formulation has been a foundational acute pain management tool in hospital and clinical settings since its approval.
As an aging injectable facing patent loss, TALWIN likely operates with a lean, maintenance-focused commercial team managing a stable but shrinking revenue base.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
TALWIN offers limited career growth potential given its LOE-approaching status and minimal linked job opportunities. Roles on this product focus on defensive commercial strategies, generic competition management, and maintaining clinical relationships rather than growth initiatives.
Worked on TALWIN at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.